申请人:OTSUKA PHARMACEUTICAL CO., LTD.
公开号:EP0382185A2
公开(公告)日:1990-08-16
Novel carbostyril derivatives of the formula:
wherein R1 is H, N02, alkoxy, alkoxycarbonyl, alkyl, halogen, optionally substituted amino, OH, CN, COOH, alkanoyloxy, hydrazinocarbonyl; q is 1 to 3, and R is a group of the formula:
[wherein R2 is H, alkoxycarbonyl, optionally substituted phenoxycarbonyl, phenylalkenyl-CO-, optionally substituted phenylalkanoyl, alkanoyl, alkenyl-CO-, optionally substituted phenyl-S02-, -CONR8R9, optionally substituted heterocyclic group-CO-, naphthyl-CO-, thienylalkanoyl, tricyclo[3.3.1.1]alkanoyl,
(R13 is OH, optionally substituted alkoxy, -NR32R33, -O-A-(E)ℓ-NR4R5, -(B)ℓ-NR6R7, etc.),
n is 1 or 2, m is 0 or 1 to 3, R3 is alkyl, R10 is -(CO)ℓ-NR11R12], and the bond between 3- and 4-position of carbostyril nucleus is single or double bond,
which have excellent vasopressin antagonistic activities and are useful as vasodilator, hypotensive agent, water diuretics, platelet agglutination inhibitor, and a vasopressin antagonistic composition containing the compound as the active ingredient.
式中的新型碳四吡啶衍生物:
其中 R1 是 H、N02、烷氧基、烷氧羰基、烷基、卤素、任选取代的氨基、OH、CN、COOH、烷酰氧基、肼基;q 是 1 至 3,R 是式中的基团:
[其中 R2 是 H、烷氧基羰基、任选取代的苯氧基羰基、苯基烯基-CO-、任选取代的苯基烷酰基、烷酰基、烯基-CO-、任选取代的苯基-S02-、-CONR8R9、任选取代的杂环基团-CO-、萘基-CO-、噻吩基烷酰基、三环[3.3.1.1]烷酰基、
(R13 为 OH、任选取代的烷氧基、-NR32R33、-O-A-(E)ℓ-NR4R5、-(B)ℓ-NR6R7 等)、
n 为 1 或 2,m 为 0 或 1 至 3,R3 为烷基,R10 为-(CO)ℓ-NR11R12],碳四吡啶核的 3 位和 4 位之间的键为单键或双键、
这些化合物具有优异的血管加压素拮抗活性,可用作血管扩张剂、降血压剂、利尿剂、血小板凝集抑制剂,以及含有该化合物作为活性成分的血管加压素拮抗组合物。